SAFETY OF LEMBOREXANT IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1)

被引：1
|
作者：
Rosenberg, Russell [1 ]
Filippov, Gleb [2 ]
LoPresti, Antonia [2 ]
Kumar, Dinesh [2 ]
Murphy, Patricia [2 ]
Moline, Margaret [2 ]
机构：
[1] NeuroTrials Res Inc, Atlanta, GA USA
[2] Eisai Inc, Tokyo, Japan
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2019年 / 27卷 / 03期
关键词：
D O I：
10.1016/j.jagp.2019.01.109
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR - 21
引用
收藏
页码：S155 / S156
页数：2
相关论文
共 50 条
  • [1] Safety of Lemborexant in Elderly Subjects with Insomnia: Results from SUNRISE 1
    Rosenberg, R.
    Filippov, G.
    LoPresti, A.
    Kumar, D.
    Moline, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S218 - S218
  • [2] EFFICACY OF LEMBOREXANT COMPARED WITH ZOLPIDEM EXTENDED RELEASE AND PLACEBO IN ELDERLY SUBJECTS WITH INSOMNIA: RESULTS FROM A PHASE 3 STUDY (SUNRISE 1)
    Zammit, Gary
    Mayleben, David
    Kumar, Dinesh
    Murphy, Patricia
    Moline, Margaret
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (03): : S154 - S155
  • [3] Efficacy and Safety of Lemborexant vs Zolpidem Extended Release and Placebo in Elderly Subjects with Insomnia: Results from SUNRISE-1
    Zammit, Gary
    Mayleben, David
    Kumar, Dinesh
    Moline, Margaret
    NEUROLOGY, 2020, 94 (15)
  • [4] Efficacy and Safety of Lemborexant in Elderly Subjects with Insomnia Disorder: Pooled Analyses from SUNRISE-1 and SUNRISE-2
    Moline, Margaret
    Yardley, Jane
    Pinner, Kate
    Kumar, Dinesh
    Bsharat, Mohammed
    Karppa, Mikko
    Zammit, Gary
    Perdomo, Carlos
    Mianulli, Caroline
    Rosenberg, Russell
    NEUROLOGY, 2020, 94 (15)
  • [5] Efficacy of Lemborexant vs Zolpidem Extended Release and Placebo in Elderly Subjects with Insomnia: Results from SUNRISE 1
    Zammit, G.
    Mayleben, D.
    Kumar, D.
    Moline, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S51 - S51
  • [6] Efficacy and Safety of Lemborexant in Elderly Subjects with Insomnia: Results of a Pooled Analysis of Two Phase 3 Trials
    Moline, M.
    Yardley, J.
    Pinner, K.
    Kumar, D.
    Bsharat, M.
    Karppa, M.
    Zammit, G.
    Perdomo, C.
    Mianulli, C.
    Rosenberg, R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S56 - S56
  • [7] IMPACT OF LEMBOREXANT ON INSOMNIA DISEASE SEVERITY AND FATIGUE IN ELDERLY SUBJECTS WITH INSOMNIA FROM SUNRISE-2
    Yardley, Jane
    Pinner, Kate
    Moline, Margaret
    Perdomo, Carlos
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S134 - S135
  • [8] Effectiveness and Safety of Lemborexant Over 12 Months in Adults with Insomnia Disorder: Longterm Results From the Phase 3 SUNRISE-2 Study
    Yardley, Jane
    Karppa, Mikko
    Inoue, Yuichi
    Pinner, Kate
    Perdomo, Carlos
    Filippov, Gleb
    Kubota, Naoki
    Moline, Margaret
    NEUROLOGY, 2020, 94 (15)
  • [9] LONG-TERM EFFICACY AND SAFETY OF LEMBOREXANT IN ELDERLY ADULTS WITH INSOMNIA DISORDER: RESULTS FROM SUNRISE-2
    Moline, M.
    Inoue, Y.
    Pinner, K.
    Perdomo, C.
    Filippov, G.
    Kubota, N.
    Yardley, J.
    SLEEP, 2020, 43 : A182 - A182
  • [10] Impact of Lemborexant Treatment on Insomnia Disease Severity and Fatigue: Results from the 12-Month Phase 3 Study SUNRISE-2
    Moline, Margaret
    Karppa, Mikko
    Yardley, Jane
    Kumar, Dinesh
    Pinner, Kate
    Perdomo, Carlos
    Filippov, Gleb
    Atkins, Norman
    NEUROLOGY, 2020, 94 (15)
12345